ATS American Thoracic Society
Recent Abstracts
Credits

Quality of Life Questionnaire for Cancer Patients Treated with Anti-Cancer Drugs (QOL-ACD)

Name of Questionnaire

Quality of Life - Anti-Cancer Drugs (QOL-ACD)

Description

Quality of life measurement tool for patients undergoing chemotherapy.

Developer

Minory Kurihara

Address

Department of Internal Medicine (Gastroenterology)
Toyosu Hospital
Showa University, 4-1-18
Toyosu, Koto-ku, Tokyo 135-8577
Japan
Tel: +81-3-35341151
Fax: +81-3-35319566

Administration

Self

Number of items

22

Domains & categories

4

Name of categories/domains

Daily Activities, Physical Condition, Social Activities, Mental and Psychological Status

Scaling of items

Five-point scale from 5 ("best" or "good") to 1 ("worst" or "bad") for 21 items. Five-point face scale for 1 item.

Scoring

Subscale scores are calculated as a simple sum of the items within each subscale: Daily Activity (#1-6), Physical Condition (#7-11), Psychological Condition (#12-16), Social Attitude (#17-21), and Face Scale (#22). The total score is the sum of the subscale scores.

Reliability

a. Test-Retest / Reproducibility Reported: Spearman correlation coefficient was over 0.5 for 17 of the 22 items. The remaining 5 items had coefficients of 0.54, 0.45, 0.44, 0.43, and 0.28. Matsumoto reported intra-class correlation coefficients to be at least moderately reliable except item 6. Also, the item-domain correlation coefficients were greater than 0.4 for all items except 10 and 16. They chose to exclude items 6 and 16 because of low test-retest reliability and poor convergent validity, respectively. This brought the range of intra-class correlation coefficients to 0.610-0.866.
b. Internal Consistency Reported: Cronbach's alpha coefficient, Daily Activity r=0.821, Physical Condition r=0.730, Psychological Condition r=0.582, Social Attitude r=0.740. In the second study (Matsumoto, 2002) which excluded 2 items, Cronbach's alpha coefficients ranged from 0.795 to 0.897.

Validity

  1. Factor analysis provided strong support for the domain structure. Factors = Functional, Psychosocial, Physical, Mental.
  2. Inter-scale correlations were calculated, and the instrument showed moderate correlations between subscales (range: 0.258 to 0.536). In the second study (Matsumoto, 2002), the coefficients ranged from 0.612 to 0.866.
  3. Concurrent validity was measured against Performance Status (PS), State-Trait Anxiety Inventory (STAI) and Self-Rating Depression Scale (SDS). Performance Status correlated moderately with Daily Activity and Physical Condition. State-Trait Anxiety Inventory correlated moderately with all but Daily Activity. Self-Rating Depression Scale correlated moderately with all of the scales. The total score correlations showed r=0.551 for Performance Status, r=0.554 for State-Trait Anxiety Inventory, and r=0.662 for Self-Rating Depression Scale. In the Matsumoto study, Pearson's correlation coefficients were calculated among the four domains and for the relationship of each domain with the face scale. All correlations among the four domains were below 0.70. Functional and physical domains showed good correlation. Modest correlations were found between the functional and mental domains (r=0.618), physical and mental domains (r=0.588), and mental and psychosocial domains (r=0.517). The face scale was most strongly correlated with the mental domain.
  4. Clinical validity: statistically significant relationships found between the functional domain and performance status, sex, or weight loss; between the physical domain and performance status, weight loss, albumin, or LDH; and between the psychosocial domain and sex or age. These relationships were determined to be clinically reasonable.

Research use

  1. Matsumoto T, Ohashi Y, Morita S, Kobayashi K, Shibuya M, Yamaji Y, Eguchi K, Fukuoka M, Nagao K, Nishiwaki Y, Niitani H. The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in Japanese patients with advanced non-small-cell lung cancer. Quality of Life Research. 2002 Aug;11(5):483-93.

Clinical use

Not reported.

Language

Japanese, English

References

  1. Kurihara M, Shimizu H, Tsuboi K, Kobayashi K, Murakami M, Eguchi K, Shimozuma K. Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psycho-Oncology. 1999 Jul-Aug;8(4):355-63.
  2. Matsumoto T, Ohashi Y, Morita S, Kobayashi K, Shibuya M, Yamaji Y, Eguchi K, Fukuoka M, K, Nishiwaki Y, Niitani H. The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in Japanese patients with advanced non-small-cell lung cancer. Quality of Life Research. 2002 Aug;11(5):483-93.Nagao

Date of information

April 2003


Copyright © 2007 American Thoracic Society · Web Site Requirements
Questions or comments? Contact Us.